Medica RCP |Aldara* | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Aldara*

May be acceptable
If it is considered to be clearly essential

Contraindicated

Aldara* :
Type	Medicine Non Marketed
Originator	B
Agent	Omnipharma
Distributor	Omnipharma
Laboratory	Meda Pharmaceuticals
Responsible Party	3M Health Care Ltd
Origin	UK
Manufacturer	3M Health Care Ltd
Origin	UK
ATC	D06BB10

Aldara* :

Cutaneous

Aldara* :

D Dermatologicals

D06 Antibiotics and chemotherapeutics for dermatological use

D06B Chemotherapeutics for topical use

D06BB Antivirals

D06BB10 imiquimod

Aldara* :

Imiquimod : 5%

Aldara* :

Adults : Actinic keratosis 3 times/week for 4 weeks

Adults : Condylomata Acuminata 3 times/week for a maximum of 16 weeks

Adults : Superficial basal cell carcinomas 5 times/week for 6 weeks

Aldara* :

Benzyl alcohol* Contraindicated in children under 3 years old

◼

Cetyl Alcohol *

Glycerin (E422) (Glycerol)*

Methyl hydroxybenzoate (E218)

Polysorbate 60 Emulsifying Agents

Propyl hydroxybenzoate

Purified water

Sorbitan stearate

Sostearic acid

Stearyl alcohol

White paraffin

Xanthan gum (E 415)

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Aldara* :

Revision Date : 27/04/2010

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal pain	Uncommon
Absolute neutrophil count decreased	Not known
Actinic keratosis	Uncommon
Anorexia	Common
Application site alopecia	Not known
Application site bleeding	Common
Application site dermatitis	Uncommon
Application site discharge	Uncommon
Application site erosion	Uncommon
Application site erythema	Common
Application site hyperaesthesia	Uncommon
Application site inflammation	Uncommon
Application site irritation	Common
Application site oedema	Uncommon
Application site pain	Very Common
Application site papules	Common
Application site paraesthesia	Common
Application site pruritus	Very Common
Application site rash	Common
Application site reaction	Common
Application site scab	Uncommon
Application site scar	Uncommon
Application site swelling	Uncommon
Application site ulcer	Uncommon
Application site vesicles	Uncommon
Application site warmth	Uncommon
Arthralgia (Pain joint) (Joint ache)	Common
Asthenia	Uncommon
Back pain	Common
Bacterial infection	Uncommon
Conjunctival irritation	Uncommon
Cutaneous lupus erythematosus	Not known
Depression	Uncommon
Dermatitis	Uncommon
Diarrhoea (Diarrhea)	Uncommon
Discomfort	Uncommon
Dizziness	Uncommon
Dry mouth (Xerostomia)	Uncommon
Dyspareunia	Uncommon
Dysuria (Micturition painful)	Uncommon
Eczema	Uncommon
Erectile dysfunction	Uncommon
Erythema	Uncommon
Erythema multiforme	Not known
Eyelid oedema	Uncommon
Face oedema	Uncommon
Fatigue	Common
Flushing	Uncommon
Folliculitis	Uncommon
Fungal infection	Uncommon
Genital candidiasis	Uncommon
Genital pain male	Uncommon
Haemoglobin decreased	Not known
Headache	Common
Hepatic enzyme increased	Not known
Herpes simplex	Uncommon
Infection	Common
Inflammation (Inflammatory reaction)	Uncommon
Influenza	Uncommon
Influenza-like illness	Uncommon
Insomnia	Uncommon
Irritability	Uncommon
Lethargy	Uncommon
Leukocyte count decreased (White blood cell count decreased)	Not known
Lymphadenopathy	Common
Malaise	Uncommon
Migraine	Uncommon
Myalgia	Common
Nasal congestion	Uncommon
Nausea	Common
Pain	Uncommon
Pain in extremity (Pain in limb)	Uncommon
Paraesthesia (paresthesia)	Uncommon
Penis disorder	Uncommon
Pharyngitis	Uncommon
Pharyngolaryngeal pain	Uncommon
Platelet count decreased (Thrombocyte count decreased)	Not known
Pruritus	Uncommon
Pyrexia	Uncommon
Rash erythematous	Uncommon
Rectal disorder	Uncommon
Rectal tenesmus	Uncommon
Rhinitis	Uncommon
Rigors	Uncommon
Skin hyperpigmentation	Not known
Skin hypopigmentation	Not known
Skin infection	Not known
Skin rash	Uncommon
Skin ulcer	Uncommon
Somnolence	Uncommon
Stevens-Johnson syndrome	Not known
Sweating increased (Excessive sweating) (Hyperhydrosis)	Uncommon
Tinnitus	Uncommon
Upper respiratory tract infection	Uncommon
Urticaria	Uncommon
Uterovaginal prolapse	Uncommon
Vaginal pain	Uncommon
Vaginitis	Uncommon
Vaginitis atrophic	Uncommon
Vomiting	Uncommon
Vulval disorder	Uncommon
Vulvitis	Uncommon

Aldara* :

Greece

Jordan

Medicine Authorised

Aldara

Omnipharma

Meda Pharmaceuticals

Medicine Authorised

Genimod

Pharmapro

Mediphar

NB : Products With Same Indication

Coming Very Soon

Different Units By MoH Code

Revision Date : 01/09/2009

Aldara* MoH 5247 :

Form Cutaneous Cream

Packaging Sachets (paper / Al / PE)

Package Size Box of 12

Strength 5%

NSSF ✘

Quarantine ✘

Reg. Number 222293/08

Submission date 01/01/2008

Registration Year 2008

Archived Date 2014

Price Comparison

● Country: Jordan

● Package Size: 12

● Public Price: 53.42 JOD ( 6,689,305.82 LBP )

● Pack size unit used: 12

● Cost/Unit: 4,4517 JOD ( 500,884.00 LBP )

● Pharmacy Price: 40.77 JOD ( 5105260.17 LBP )

● Reference: JFDA

● Pricing Date: 02/01/2021

● Type: Medicine Authorised

● Country: Greece

● Package Size: 12

● Public Price: 62.51 EUR ( 6,055,718.76 LBP )

● Pack size unit used: 12

● Cost/Unit: 5,2092 EUR ( 484,380.00 LBP )

● Exfactory Price: 43.24 EUR

● Pharmacy Price: 45.36 EUR ( 4394295.36 LBP )

● Reference: National Organization for Medicines

● Pricing Date: 25/02/2021

● Type: Medicine Authorised

◼ Lebanon

◼ Country of Origin

◼ Reference Countries

◼ Other Countries

Note

Prices are provided in Dollar ($)

You have to register to view this info

Visitors Count: 30971257

Form	Cutaneous Cream
Packaging	Sachets (paper / Al / PE)
Package Size	Box of 12
Strength	5%
NSSF	✘
Quarantine	✘
Reg. Number	222293/08
Submission date	01/01/2008
Registration Year	2008
Archived Date	2014

● Country:	Jordan
● Package Size:	12
● Public Price:	53.42 JOD	( 6,689,305.82 LBP )
● Pack size unit used:	12
● Cost/Unit:	4,4517 JOD	( 500,884.00 LBP )
● Pharmacy Price:	40.77 JOD	( 5105260.17 LBP )
● Reference:	JFDA
● Pricing Date:	02/01/2021
● Type:	Medicine Authorised